Pharmaceutical Company Registration in Pakistan
Complete Guide to DRAP Registration, Drug Manufacturing License & GMP Compliance 2025
📋 Table of Contents
- Introduction to Pharmaceutical Industry in Pakistan
- Regulatory Framework & DRAP Overview
- Company Registration with SECP
- DRAP Registration Process
- Drug Manufacturing License Requirements
- GMP Compliance Standards
- Import/Export Licenses for Pharmaceuticals
- Quality Control & Testing Requirements
- Marketing Approvals & Drug Registration
- Costs & Timeline Breakdown
- Related Resources
- Frequently Asked Questions
Introduction to Pharmaceutical Industry in Pakistan
The pharmaceutical industry in Pakistan is one of the most regulated and critical sectors of the economy, contributing significantly to healthcare delivery and economic growth. With over 800 licensed pharmaceutical manufacturers and a market value exceeding $4 billion, Pakistan's pharmaceutical sector serves both domestic and international markets. Establishing a pharmaceutical company in Pakistan requires navigating complex regulatory frameworks, obtaining multiple licenses, and ensuring strict compliance with quality and safety standards.
The Drug Regulatory Authority of Pakistan (DRAP) serves as the primary regulatory body overseeing all aspects of pharmaceutical manufacturing, import, distribution, and marketing. Whether you're planning to manufacture medicines, import pharmaceutical products, or establish a distribution network, understanding the complete registration process is essential for legal operation and long-term success. This comprehensive guide covers every aspect of pharmaceutical company registration in Pakistan, from initial company formation to obtaining manufacturing licenses and marketing approvals.
The process involves multiple stages including company registration with the Securities and Exchange Commission of Pakistan (SECP), obtaining various licenses from DRAP, ensuring Good Manufacturing Practices (GMP) compliance, and securing necessary approvals for specific pharmaceutical products. Each stage requires careful documentation, facility inspections, and adherence to international quality standards. The pharmaceutical sector demands the highest levels of regulatory compliance to ensure public health and safety.
💡 Key Statistics
Market Size: $4+ billion annually | Licensed Manufacturers: 800+ companies | Export Value: $300+ million | Growth Rate: 10-12% annually | Employment: 150,000+ direct and indirect jobs
🚀 Ready to Start Your Pharmaceutical Company?
Get expert guidance on pharmaceutical company registration, DRAP licensing, and GMP compliance
Regulatory Framework & DRAP Overview
The Drug Regulatory Authority of Pakistan (DRAP) was established in 2012 under the DRAP Act 2012, consolidating all drug regulatory functions previously scattered across various government departments. DRAP is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products available in Pakistan. The authority regulates the manufacture, import, export, sale, distribution, and marketing of drugs, medical devices, and other therapeutic goods.
Key Regulatory Bodies and Their Roles
| Regulatory Body | Primary Responsibilities | Key Functions |
|---|---|---|
| DRAP (Drug Regulatory Authority of Pakistan) | Overall pharmaceutical regulation and licensing | Manufacturing licenses, drug registration, GMP inspections, import/export permits |
| SECP (Securities & Exchange Commission) | Company registration and corporate compliance | Company incorporation, annual filings, corporate governance |
| Ministry of National Health Services | Policy formulation and oversight | Healthcare policies, drug pricing, strategic planning |
| Provincial Health Departments | Regional compliance and enforcement | Local inspections, retail licensing, enforcement actions |
| FBR (Federal Board of Revenue) | Tax registration and compliance | NTN registration, sales tax, income tax compliance |
Legal Framework Governing Pharmaceuticals
- DRAP Act 2012: Primary legislation establishing DRAP and its regulatory powers
- Drugs Act 1976: Governs manufacture, sale, and distribution of drugs
- Drug (Licensing, Registering and Advertising) Rules 1976: Detailed rules for licensing and registration
- Pharmacy Act 1967: Regulates pharmacy profession and practice
- Drug (Pricing and Distribution) Rules: Controls drug pricing and distribution
- Import Policy Orders: Regulates pharmaceutical imports
- Companies Act 2017: Governs company formation and operations
✅ Compliance is Mandatory
Non-compliance with pharmaceutical regulations can result in severe penalties including license suspension, heavy fines (up to PKR 10 million), product recalls, criminal prosecution, and imprisonment. DRAP conducts regular inspections and market surveillance to ensure compliance.
Company Registration with SECP
Before applying for pharmaceutical licenses from DRAP, you must first register your company with the Securities and Exchange Commission of Pakistan (SECP). The type of company structure you choose will depend on your business scale, investment capacity, and operational plans. Most pharmaceutical manufacturers opt for a Private Limited Company structure due to its advantages in terms of limited liability, easier fundraising, and professional credibility.
Company Structure Options for Pharmaceutical Business
Recommended Company Structures
1. Private Limited Company (Most Common)
Advantages: Limited liability protection, separate legal entity, easier to raise capital, professional credibility, better for scaling operations
Requirements: Minimum 2 directors, minimum 2 shareholders, minimum capital PKR 100,000
Best For: Medium to large-scale pharmaceutical manufacturing, import/export businesses
2. Single Member Company
Advantages: Single owner, limited liability, lower compliance burden than Pvt Ltd
Requirements: One director/shareholder, minimum capital PKR 100,000
Best For: Small-scale pharmaceutical operations, distribution businesses
3. Public Limited Company
Advantages: Can raise public capital, unlimited growth potential, can list on stock exchange
Requirements: Minimum 3 directors, minimum 7 shareholders, minimum capital PKR 3,000,000
Best For: Large-scale pharmaceutical manufacturers planning IPO or major expansion
SECP Registration Process for Pharmaceutical Company
Step 1: Name Reservation (1-2 days)
Reserve your company name through SECP's online portal. The name should not be similar to existing companies and must comply with naming guidelines. For pharmaceutical companies, the name should clearly indicate the pharmaceutical nature of business.
Step 2: Document Preparation (2-3 days)
Prepare incorporation documents including Memorandum & Articles of Association, Form 1 (Declaration), Form 21 (Notice of Registered Office), Form 29 (Particulars of Directors), and supporting documents like CNIC copies, photographs, and utility bills.
Step 3: Online Submission (1 day)
Submit all documents through SECP's eServices portal with the required incorporation fee. Ensure all documents are properly attested and comply with SECP requirements.
Step 4: Certificate of Incorporation (3-5 days)
Upon approval, SECP issues the Certificate of Incorporation along with Memorandum & Articles of Association. This legally establishes your company as a separate entity.
Step 5: Post-Incorporation Compliance (1-2 days)
Complete post-incorporation requirements including NTN registration with FBR, opening company bank account, and obtaining digital signatures for directors.
⚠️ Important Requirements for Pharmaceutical Companies
At least one director must have a pharmaceutical background (B.Pharmacy or equivalent qualification). The Memorandum of Association must specifically include pharmaceutical manufacturing, import, export, or distribution in the business objectives. SECP may require additional documentation for pharmaceutical businesses due to the regulated nature of the industry.
📞 Need Help with Company Registration?
Our experts at Sterling Pakistan can handle your complete SECP registration process
DRAP Registration Process
Once your company is registered with SECP, the next crucial step is obtaining registration and licensing from the Drug Regulatory Authority of Pakistan (DRAP). This process involves multiple licenses and approvals depending on your business activities. DRAP registration is mandatory for all pharmaceutical activities including manufacturing, import, export, wholesale, and retail distribution of pharmaceutical products.
Types of DRAP Licenses Required
| License Type | Purpose | Validity Period | Approximate Fee |
|---|---|---|---|
| Manufacturing License | Authorization to manufacture pharmaceutical products | 1 year (renewable) | PKR 50,000 - 200,000 |
| Import Registration Certificate (IRC) | Permission to import pharmaceutical products | 3 years (renewable) | PKR 25,000 - 100,000 |
| Export Registration Certificate | Authorization to export pharmaceutical products | 3 years (renewable) | PKR 25,000 - 75,000 |
| Wholesale License | Permission for wholesale distribution | 1 year (renewable) | PKR 15,000 - 50,000 |
| Drug Registration Certificate | Approval for specific drug products | 5 years (renewable) | PKR 10,000 - 50,000 per product |
DRAP Registration Requirements
- Company Documentation: Certificate of Incorporation, Memorandum & Articles of Association, NTN Certificate, Board Resolution
- Facility Documentation: Ownership/lease documents for premises, floor plans, layout diagrams, utility connections
- Technical Staff: Qualified pharmacist (B.Pharmacy minimum), technical staff credentials, employment contracts
- Equipment Details: List of manufacturing equipment, testing equipment, quality control instruments
- Quality Systems: Standard Operating Procedures (SOPs), Quality Manual, GMP compliance documentation
- Financial Proof: Bank statements, paid-up capital evidence, financial capacity documents
- Safety Measures: Fire safety arrangements, waste disposal systems, environmental compliance
Step-by-Step DRAP Registration Process
Stage 1: Preliminary Application (Week 1-2)
Submit preliminary application to DRAP with company details, proposed business activities, facility location, and technical staff qualifications. DRAP reviews the application and may request additional information or clarifications.
Stage 2: Facility Preparation (Month 1-3)
Prepare your facility according to GMP standards including proper zones for manufacturing, testing, storage, and administration. Install required equipment and implement quality management systems. This is the most time-intensive phase requiring significant investment.
Stage 3: Documentation Submission (Week 1-2)
Submit complete documentation package to DRAP including all technical, facility, and compliance documents. Ensure all SOPs, quality manuals, and operational procedures are properly documented and comply with regulatory requirements.
Stage 4: DRAP Inspection (Week 2-4)
DRAP inspection team visits your facility to verify compliance with GMP standards, equipment adequacy, quality systems, and overall readiness. The inspection is thorough and covers all aspects of pharmaceutical operations including production areas, testing laboratories, storage facilities, and documentation systems.
Stage 5: Deficiency Correction (If Required - Week 1-4)
If DRAP identifies deficiencies during inspection, you must address all issues and request re-inspection. Common deficiencies include inadequate quality systems, incomplete SOPs, equipment calibration issues, or facility shortcomings.
Stage 6: License Issuance (Week 2-4)
Upon successful inspection and compliance verification, DRAP issues the relevant license(s). You receive official license documents allowing you to commence pharmaceutical operations as per the scope of your license.
⏱️ Total Timeline for DRAP Registration
Minimum Duration: 4-6 months (with no major deficiencies) | Average Duration: 6-9 months | Maximum Duration: 12-18 months (with multiple re-inspections or facility improvements required)
Drug Manufacturing License Requirements
The drug manufacturing license is the most critical authorization for pharmaceutical companies planning to produce medicines in Pakistan. This license is issued by DRAP after rigorous assessment of your facility, equipment, technical capabilities, quality systems, and compliance with Good Manufacturing Practices (GMP). The manufacturing license specifies the types of dosage forms you are authorized to manufacture.
Categories of Manufacturing Licenses
Pharmaceutical Manufacturing Categories
| Dosage Form Category | Products Covered | Facility Requirements | Investment Range |
|---|---|---|---|
| Oral Solid Dosage Forms | Tablets, capsules, powders | Separate compression, coating, packaging areas; HVAC systems; dust control | PKR 50-200 million |
| Oral Liquid Dosage Forms | Syrups, suspensions, solutions | Mixing vessels, filtration systems, filling lines, microbiology lab | PKR 30-150 million |
| Injectable Dosage Forms | Ampoules, vials, IV solutions | Class A cleanrooms, LAF units, autoclave, depyrogenation, extensive testing facility | PKR 200-500 million |
| Topical/External Dosage Forms | Creams, ointments, lotions, gels | Homogenizers, filling machines, controlled temperature storage | PKR 20-100 million |
| Sterile Ophthalmic Products | Eye drops, eye ointments | Class A/B cleanrooms, specialized filling equipment, extensive testing | PKR 100-300 million |
Essential Manufacturing Facility Requirements
1. Infrastructure Requirements
- Building Structure: Minimum 5,000-10,000 sq ft dedicated manufacturing space with proper zoning and segregation of areas
- Production Areas: Separate zones for dispensing, manufacturing, packaging, and quarantine with appropriate environmental controls
- Quality Control Laboratory: Fully equipped QC lab with analytical instruments (HPLC, UV-Vis, dissolution tester, etc.)
- Warehouse Facilities: Climate-controlled storage for raw materials, packaging materials, and finished products
- HVAC System: Air handling units maintaining required temperature (20-25°C), humidity (45-55% RH), and air changes
- Water System: Purified water generation and distribution system meeting pharmacopoeia standards
- Effluent Treatment: Proper waste disposal and effluent treatment plant as per environmental regulations
2. Equipment Requirements
| Equipment Category | Essential Equipment | Purpose |
|---|---|---|
| Production Equipment | Mixers, granulators, tablet compression machines, coating pans, filling machines | Manufacturing operations |
| Testing Equipment | HPLC, UV-Vis spectrophotometer, dissolution apparatus, moisture analyzer, microbiology equipment | Quality control and testing |
| Packaging Equipment | Blister packing machines, strip packers, carton sealers, labeling machines | Primary and secondary packaging |
| Utilities | Water purification system, compressed air system, nitrogen generation, backup generators | Support systems |
| Calibration Tools | Reference weights, thermometers, pressure gauges, humidity meters | Equipment calibration and validation |
3. Technical Staff Requirements
- Production Pharmacist: B.Pharmacy degree with DRAP registration (mandatory requirement)
- Quality Control Manager: M.Pharmacy or equivalent with relevant experience in pharmaceutical analysis
- Production Manager: Pharmaceutical background with manufacturing experience
- Quality Assurance Officer: Responsible for GMP compliance and quality systems
- Microbiologist: For sterile product manufacturing and environmental monitoring
- Support Staff: Trained operators, technicians, and quality control analysts
⚠️ Critical Compliance Points
1. Qualified Person Requirement: A registered pharmacist must be present during production hours and is legally responsible for product quality.
2. Equipment Validation: All manufacturing and testing equipment must be installed, calibrated, and validated before production begins.
3. Documentation: Comprehensive SOPs covering all operations, detailed batch manufacturing records, and complete quality documentation are mandatory.
4. Environmental Compliance: NOC from Environmental Protection Agency required for waste disposal and emissions.
🏭 Planning Your Pharmaceutical Manufacturing Setup?
Get comprehensive consultation on facility design, equipment selection, and licensing requirements
GMP Compliance Standards
Good Manufacturing Practices (GMP) compliance is the cornerstone of pharmaceutical manufacturing in Pakistan. DRAP has adopted WHO GMP guidelines with local adaptations, making GMP compliance mandatory for all pharmaceutical manufacturers. GMP ensures that products are consistently produced and controlled according to quality standards, minimizing risks of contamination, errors, and deviations that could compromise product safety and efficacy.
Core GMP Principles
1. Quality Management System
Establish comprehensive quality systems including Quality Assurance (QA) and Quality Control (QC) functions. Implement documented procedures for all critical operations, change control systems, deviation management, and continuous improvement programs.
2. Personnel & Training
Maintain qualified staff with appropriate education, training, and experience. Implement ongoing training programs covering GMP, SOPs, safety, and hygiene. Document all training activities and maintain competency records.
3. Premises & Equipment
Design, construct, and maintain facilities to suit manufacturing operations. Ensure proper segregation of areas to prevent cross-contamination. Maintain equipment in validated state with regular calibration and maintenance.
4. Documentation & Records
Maintain comprehensive documentation system including master formulas, batch manufacturing records, SOPs, and quality records. Ensure traceability of all materials and products. Keep records for minimum required retention periods.
5. Production Controls
Implement validated processes with in-process controls. Prevent cross-contamination through proper cleaning and segregation. Use calibrated equipment and maintain environmental monitoring in critical areas.
6. Quality Control
Establish QC laboratory with validated test methods. Test all batches against specifications. Implement stability testing programs. Investigate out-of-specification results and implement corrective actions.
GMP Documentation Requirements
| Document Type | Contents | Retention Period |
|---|---|---|
| Master Formula | Complete formulation, process parameters, specifications | Life of product + 1 year after discontinuation |
| Batch Manufacturing Record (BMR) | Complete production record including yields, deviations, QC results | Minimum 3 years after expiry |
| Standard Operating Procedures (SOPs) | Detailed instructions for all operations and processes | Current version + 1 superseded version |
| Validation Reports | Equipment, process, cleaning, and analytical method validations | Life of equipment/process |
| Quality Control Records | Raw material, in-process, and finished product testing records | Minimum 3 years after expiry |
| Stability Data | Ongoing stability studies and annual reviews | Life of product + 5 years |
DRAP GMP Inspection Checklist
- Quality System: Quality manual, organizational chart, job descriptions, change control procedures, CAPA system
- Facility: Layout compliance, segregation of areas, pest control, sanitation, environmental monitoring
- Equipment: Equipment list, calibration records, maintenance schedules, cleaning validation
- Materials: Supplier qualification, material testing, quarantine system, storage conditions
- Production: Batch records, process validation, in-process controls, yield reconciliation
- Quality Control: Lab equipment, test methods, reference standards, stability program
- Complaints & Recalls: Complaint handling system, recall procedures, market surveillance
- Self-Inspection: Internal audit program, corrective actions, management reviews
✅ GMP Certification Process
Initial Certification: Facility inspection by DRAP GMP team, review of documentation, assessment of compliance level. Maintenance: Annual renewal required with re-inspection every 2-3 years. Surveillance: DRAP may conduct unannounced inspections at any time to verify ongoing compliance. Serious GMP violations can result in license suspension or cancellation.
Import/Export Licenses for Pharmaceuticals
Pharmaceutical import and export activities in Pakistan are strictly regulated to ensure safety, quality, and compliance with international standards. Companies engaged in importing or exporting pharmaceutical products must obtain specific licenses from DRAP in addition to complying with customs regulations and international trade requirements.
Import Registration Certificate (IRC)
The Import Registration Certificate is mandatory for importing pharmaceutical raw materials, finished products, medical devices, or surgical instruments into Pakistan. DRAP issues IRC after verifying the company's infrastructure, qualified staff, and ability to maintain proper storage and distribution conditions.
IRC Requirements and Process
| Requirement Category | Specific Requirements | Documentation |
|---|---|---|
| Company Status | Registered pharmaceutical company with SECP | Incorporation certificate, MOA, NTN certificate |
| Storage Facility | Adequate warehouse with temperature control (15-25°C), humidity control, security | Ownership/lease documents, floor plans, photos |
| Technical Staff | Registered pharmacist, qualified warehouse staff | Degrees, registration certificates, employment letters |
| Quality Systems | Receipt, storage, distribution SOPs; temperature monitoring; complaint handling | Quality manual, SOPs, record formats |
| Financial Capacity | Minimum paid-up capital PKR 5 million (varies by category) | Bank statements, audited accounts |
Categories of Import Activities
- Raw Material Import: Active pharmaceutical ingredients (APIs), excipients, packaging materials
- Finished Product Import: Branded and generic medicines for distribution in Pakistan
- Medical Devices: Diagnostic equipment, surgical instruments, disposables
- Biological Products: Vaccines, blood products, biotechnology products (additional requirements apply)
Export Registration and Procedures
Pakistan exports pharmaceutical products worth over $300 million annually to countries in Asia, Africa, and Latin America. Obtaining export registration from DRAP enables Pakistani manufacturers to access international markets while ensuring compliance with destination country requirements.
Export Certificate Types
1. Certificate of Pharmaceutical Product (CPP)
WHO-format certificate confirming product registration and GMP compliance in Pakistan. Required by most importing countries for registration purposes. Valid for specific product and manufacturer combination.
2. Free Sale Certificate
Certifies that product is freely sold in Pakistan without restrictions. Required by some countries for customs clearance. Issued based on valid manufacturing license and product registration.
3. GMP Certificate
Confirms manufacturing facility compliance with WHO GMP standards. Often required alongside product certificates. Facility-specific certificate valid for all products manufactured at the site.
4. Export License
General authorization for exporting pharmaceutical products. Required for customs clearance. Renewable annually with DRAP.
Export Process Timeline
Step 1: Export License Application (2-4 weeks)
Submit application to DRAP with company documents, manufacturing license, GMP certificate, and export plan.
Step 2: Product Registration in Pakistan (if not already registered)
Products must be registered with DRAP before export certificates can be issued. Timeline varies based on product type.
Step 3: Certificate Applications (1-2 weeks per certificate)
Apply for specific certificates (CPP, Free Sale) for each product-market combination. Provide product details, registration information, and destination country requirements.
Step 4: Customs Registration (ongoing)
Register as exporter with Pakistan Customs, obtain Export Registration Number (ERN), comply with customs procedures for each shipment.
💡 International Compliance
Destination Country Requirements: Research importing country's pharmaceutical regulations before export. Quality Standards: Products must meet destination country standards (USP, BP, EP, etc.). Labeling: Comply with destination country labeling requirements including language, warnings, and storage conditions. Documentation: Maintain comprehensive export records for regulatory and tax purposes.
Quality Control & Testing Requirements
Robust quality control is fundamental to pharmaceutical manufacturing. DRAP mandates that every pharmaceutical manufacturer establish a fully functional quality control laboratory capable of testing raw materials, in-process samples, and finished products. The QC lab must be equipped with calibrated instruments, validated test methods, and qualified personnel to ensure products meet required specifications and safety standards.
Essential QC Laboratory Equipment
| Equipment | Purpose | Tests Performed | Approximate Cost |
|---|---|---|---|
| HPLC System | Quantitative and qualitative analysis | Assay, impurity testing, stability studies | PKR 3-8 million |
| UV-Vis Spectrophotometer | Identification and assay | API identification, dissolution, assay | PKR 0.5-2 million |
| Dissolution Apparatus | In-vitro release testing | Dissolution testing of tablets/capsules | PKR 1-3 million |
| FT-IR Spectrometer | Raw material identification | Identity testing of APIs and excipients | PKR 2-5 million |
| Disintegration Tester | Tablet disintegration | Disintegration time testing | PKR 0.2-0.5 million |
| Moisture Analyzer | Moisture content determination | Loss on drying, water content | PKR 0.3-0.8 million |
| pH Meter | pH measurement | Solution pH, liquid products | PKR 0.05-0.2 million |
| Microbiology Equipment | Sterility and microbial testing | Sterility, microbial limits, endotoxin | PKR 1-3 million |
| Stability Chambers | Stability testing | Accelerated and long-term stability | PKR 0.5-2 million |
Mandatory Testing Requirements
Raw Material Testing
- Identity Tests: Verify correct material received (FTIR, UV, chemical reactions)
- Assay: Confirm potency/purity meets specifications (typically 98-102% for APIs)
- Impurities: Test for related substances, heavy metals, residual solvents
- Physical Tests: Particle size, bulk density, moisture content, melting point
- Microbiological Tests: Microbial limits for non-sterile materials
In-Process Testing
- Blend Uniformity: Ensure uniform distribution of API in powder blend
- Content Uniformity: Test API content in individual dosage units
- Weight Variation: Monitor tablet/capsule weight during production
- Hardness & Friability: Mechanical strength of tablets
- Disintegration Time: Time required for dosage form breakdown
Finished Product Testing
Complete Testing Panel for Oral Solid Dosage Forms
Physical Tests
Appearance, identification, average weight, weight variation, thickness, hardness, friability, disintegration time
Chemical Tests
Assay (90-110% label claim), dissolution (minimum 80% in specified time), content uniformity, related substances
Microbiological Tests
Total aerobic microbial count, total yeast and mold count, absence of specified organisms (E. coli, Salmonella, etc.)
Packaging Tests
Seal integrity, moisture permeability, light transmission (for light-sensitive products)
Stability Testing Program
Stability testing is mandatory to establish shelf life and storage conditions. DRAP requires pharmaceutical companies to conduct stability studies according to ICH guidelines adapted for Pakistan's climatic conditions (Zone IVb - hot and humid).
| Study Type | Conditions | Duration | Testing Frequency |
|---|---|---|---|
| Long-term Stability | 30°C ± 2°C / 65% RH ± 5% | 12-36 months | 0, 3, 6, 9, 12, 18, 24, 36 months |
| Accelerated Stability | 40°C ± 2°C / 75% RH ± 5% | 6 months minimum | 0, 3, 6 months |
| Intermediate Stability | 30°C ± 2°C / 65% RH ± 5% | 12 months | 0, 6, 9, 12 months |
⚠️ Quality Control Non-Compliance Consequences
Product Release Delays: Cannot release products without complete QC testing and approval. Market Recalls: Quality failures require market recall with significant financial losses. License Suspension: Repeated quality failures can lead to manufacturing license suspension. Legal Liability: Quality-related adverse events may result in legal action and compensation claims.
Marketing Approvals & Drug Registration
Before any pharmaceutical product can be marketed and sold in Pakistan, it must obtain marketing approval from DRAP through the drug registration process. Each product requires separate registration, and the process involves extensive evaluation of safety, efficacy, quality data, and compliance with regulatory standards. Drug registration is product-specific and typically valid for five years, subject to renewal.
Drug Registration Categories
| Registration Type | Description | Typical Timeline | Registration Fee |
|---|---|---|---|
| New Chemical Entity (NCE) | Novel drug molecule never registered before | 18-36 months | PKR 100,000-300,000 |
| Generic Drug | Bioequivalent version of approved innovator product | 9-18 months | PKR 25,000-75,000 |
| Biological Product | Vaccines, biosimilars, blood products | 24-48 months | PKR 200,000-500,000 |
| Herbal/Alternative Medicine | Plant-based or traditional medicines | 6-12 months | PKR 15,000-50,000 |
| OTC (Over-the-Counter) | Non-prescription medicines | 6-12 months | PKR 20,000-60,000 |
Drug Registration Process
Stage 1: Dossier Preparation (1-3 months)
Compile comprehensive registration dossier in Common Technical Document (CTD) format containing pharmaceutical, non-clinical, and clinical data. Include manufacturing details, quality specifications, stability data, and proposed labeling.
Stage 2: Online Submission (1 week)
Submit electronic dossier through DRAP's online portal with required application forms and payment of registration fee. Ensure all documents are properly formatted and complete.
Stage 3: Preliminary Screening (2-4 weeks)
DRAP reviews application for completeness and administrative compliance. May request additional information or clarifications at this stage.
Stage 4: Technical Evaluation (3-12 months)
Detailed evaluation by DRAP technical committees covering pharmaceutical quality, preclinical data, clinical efficacy/safety, and manufacturing compliance. Multiple rounds of queries common.
Stage 5: Label Review & Approval (1-2 months)
Review and approval of product labeling including package insert, carton, and primary labels. Must comply with DRAP labeling guidelines.
Stage 6: Registration Certificate Issuance (2-4 weeks)
Upon satisfactory evaluation, DRAP issues Drug Registration Certificate valid for 5 years. Product can now be manufactured and marketed.
Registration Dossier Requirements
Common Technical Document (CTD) Modules
- Module 1 - Administrative Information: Application forms, product information, GMP certificates, manufacturing authorization
- Module 2 - Summaries: Quality overall summary, non-clinical overview, clinical overview and summary
- Module 3 - Quality: Drug substance and drug product information, specifications, analytical methods, stability data, container/closure system
- Module 4 - Non-clinical Study Reports: Pharmacology, pharmacokinetics, toxicology studies (for NCEs)
- Module 5 - Clinical Study Reports: Clinical pharmacology, efficacy, and safety data (for NCEs)
Special Requirements for Generic Products
Bioequivalence Requirements
Generic drugs must demonstrate bioequivalence to the reference product through comparative bioavailability studies. DRAP accepts studies conducted at DRAP-approved bioequivalence centers in Pakistan or recognized international facilities.
Biowaivers
BCS Class I drugs and certain other products may qualify for biowaiver, eliminating the need for human bioequivalence studies. Must demonstrate pharmaceutical equivalence and satisfactory in-vitro dissolution.
Comparative Dissolution
Even with bioequivalence studies, comparative dissolution data in multiple pH media required to demonstrate similar in-vitro performance.
Post-Registration Obligations
- Annual Product Review: Submit annual reports on production, sales, and quality issues
- Adverse Event Reporting: Report serious adverse drug reactions within mandated timelines
- Post-Marketing Surveillance: Participate in pharmacovigilance activities and safety monitoring
- Registration Renewal: Apply for renewal 6 months before expiry with updated stability data
- Variation Applications: Obtain approval for any changes to approved product (formulation, manufacturing site, specifications)
- Product Recalls: Notify DRAP immediately and conduct recalls if quality issues identified
✅ Expedited Review Programs
Fast Track Registration: Available for essential medicines, oncology products, and drugs addressing unmet medical needs. Reduced evaluation timeline of 6-9 months. Priority Review: Emergency use authorizations during public health crises (e.g., COVID-19 vaccines). Criteria: Significant therapeutic advantage, life-threatening conditions, limited treatment options.
📋 Need Help with Drug Registration?
Expert assistance with registration dossiers, DRAP submissions, and regulatory compliance
Costs & Timeline Breakdown
Establishing a pharmaceutical company in Pakistan requires substantial capital investment and time commitment. The total cost varies significantly based on the scope of operations, dosage forms to be manufactured, facility size, and level of automation. Below is a comprehensive breakdown of costs and timelines for different aspects of pharmaceutical company setup.
Complete Cost Breakdown
Initial Setup Costs (Small to Medium Scale Manufacturing)
Detailed Cost Analysis by Category
| Cost Category | Small Scale (PKR) | Medium Scale (PKR) | Large Scale (PKR) |
|---|---|---|---|
| Company Registration (SECP) | 50,000 - 100,000 | 100,000 - 150,000 | 150,000 - 300,000 |
| NTN & Tax Registration | 20,000 - 50,000 | 50,000 - 75,000 | 75,000 - 150,000 |
| Land Purchase/Lease (5000-20000 sq ft) | 5 - 15 million | 15 - 40 million | 40 - 100 million |
| Building Construction/Renovation | 5 - 15 million | 15 - 35 million | 35 - 80 million |
| Manufacturing Equipment | 10 - 25 million | 25 - 60 million | 60 - 200 million |
| QC Laboratory Equipment | 3 - 8 million | 8 - 15 million | 15 - 40 million |
| HVAC System | 2 - 5 million | 5 - 12 million | 12 - 30 million |
| Water Treatment System | 0.5 - 2 million | 2 - 4 million | 4 - 10 million |
| Effluent Treatment Plant | 0.5 - 1.5 million | 1.5 - 3 million | 3 - 8 million |
| DRAP Licensing Fees | 300,000 - 800,000 | 800,000 - 1.5 million | 1.5 - 3 million |
| Drug Registration (per product) | 25,000 - 50,000 | 50,000 - 100,000 | 100,000 - 300,000 |
| Consultant/Professional Fees | 500,000 - 1.5 million | 1.5 - 3 million | 3 - 8 million |
| Working Capital (6 months) | 5 - 10 million | 10 - 25 million | 25 - 60 million |
| TOTAL ESTIMATED INVESTMENT | 32 - 83 million | 83 - 203 million | 203 - 620 million |
Recurring Annual Costs
| Annual Expense | Estimated Cost (PKR/Year) |
|---|---|
| License Renewal Fees (DRAP) | 200,000 - 800,000 |
| Staff Salaries (20-50 employees) | 10 - 30 million |
| Utilities (electricity, gas, water) | 2 - 6 million |
| Raw Materials | 20 - 100 million |
| Quality Control Testing | 1 - 5 million |
| Maintenance & Calibration | 1 - 3 million |
| Marketing & Distribution | 5 - 20 million |
| Regulatory Compliance | 500,000 - 2 million |
Complete Timeline for Pharmaceutical Company Setup
Month 1-2: Company Formation & Planning
SECP registration, NTN registration, business plan finalization, site selection, preliminary license applications
Month 3-6: Facility Development
Land acquisition/lease, building construction or renovation, architectural planning, HVAC design, utility connections
Month 7-9: Equipment Installation
Manufacturing equipment procurement and installation, QC lab setup, water treatment system, effluent treatment plant
Month 10-11: Validation & Documentation
Equipment qualification (IQ/OQ/PQ), cleaning validation, analytical method validation, SOP preparation, quality manual development
Month 12-14: DRAP Licensing
Manufacturing license application, DRAP inspection, deficiency rectification (if any), license issuance
Month 15-18: Product Registration
Drug registration dossier preparation, submission to DRAP, evaluation process, marketing approval
Month 19-20: Trial Production
Pilot batches, process optimization, stability studies initiation, packaging validation
Month 21-24: Commercial Production Launch
Commercial production commencement, distribution network establishment, market launch
💰 Financing Options
Bank Financing: Most commercial banks offer project financing for pharmaceutical manufacturing at 13-18% markup rates. Typically 70-80% financing available. SBP Schemes: State Bank offers special financing schemes for exports and value-added sectors. Equity Partners: Consider bringing in equity partners or venture capital for larger projects. Vendor Financing: Some equipment suppliers offer deferred payment plans.
Frequently Asked Questions (FAQs)
The minimum investment for starting a small-scale pharmaceutical manufacturing company in Pakistan ranges from PKR 30-50 million. This includes company registration, facility setup, basic manufacturing equipment, quality control laboratory, licensing fees, and initial working capital. For oral solid dosage forms (tablets/capsules), you can start with approximately PKR 40 million, while injectable manufacturing requires PKR 200+ million due to stringent cleanroom and equipment requirements. The actual investment depends on factors like dosage forms to be manufactured, production capacity, level of automation, and facility location. Working capital for 6 months of operations should also be factored into your budget.
The complete process of obtaining a drug manufacturing license from DRAP typically takes 6-12 months, assuming your facility is fully prepared and compliant with GMP standards. The timeline breaks down as follows: preliminary application and review (2-4 weeks), facility preparation and documentation (this varies but usually 3-6 months if starting from scratch), formal license application submission (1-2 weeks), DRAP facility inspection (2-4 weeks after submission), addressing deficiencies if any (variable time), and final license issuance (2-4 weeks). However, if you face major deficiencies during inspection or if your facility requires significant modifications, the process can extend to 12-18 months. It's crucial to ensure complete GMP compliance before applying to avoid delays.
DRAP mandates specific educational qualifications for key personnel in pharmaceutical companies. The most critical requirement is a registered pharmacist with a B.Pharmacy degree who must be present during production hours and is legally responsible as the "authorized person." The Quality Control Manager should have an M.Pharmacy degree or equivalent with expertise in pharmaceutical analysis and quality control. The Production Manager needs a pharmaceutical background (B.Pharmacy minimum) with relevant manufacturing experience. For companies manufacturing sterile products, a qualified microbiologist is mandatory. Quality Assurance personnel should have appropriate pharmaceutical education and training in GMP and regulatory compliance. All technical staff must undergo continuous GMP training, and comprehensive training records must be maintained. Additionally, pharmacists must be registered with the relevant provincial pharmacy council.
Yes, you can import and distribute pharmaceutical products without manufacturing by obtaining an Import Registration Certificate (IRC) from DRAP. This requires: registering your company with SECP as a pharmaceutical import/distribution business, having adequate warehouse facilities with proper storage conditions (temperature and humidity control), employing a registered pharmacist, demonstrating financial capacity (minimum paid-up capital requirements vary but typically PKR 5 million+), and implementing proper storage, handling, and distribution procedures. You must also register each imported product with DRAP before commercial import and sale. The IRC process takes 3-6 months and costs approximately PKR 50,000-150,000 depending on the scope. Import-only operations require significantly less capital investment (PKR 10-20 million) compared to manufacturing. However, you must comply with all quality and safety regulations, and the registered pharmacist remains legally responsible for product quality during storage and distribution.
Ongoing compliance requirements for licensed pharmaceutical manufacturers in Pakistan are extensive and include: Annual license renewal with DRAP (must apply 60 days before expiry), regular self-inspections and internal audits to maintain GMP compliance, periodic DRAP GMP inspections (typically every 2-3 years, but can be unannounced), continuous quality control testing of all products, stability testing programs for all registered products, adverse event reporting to DRAP within specified timelines, annual production and quality reports submission to DRAP, maintaining all manufacturing and quality records as per retention requirements (typically 3 years after product expiry), equipment calibration and maintenance as per schedules, ongoing staff training and competency assessments, prompt reporting and investigation of quality complaints and deviations, product recall procedures and implementation when necessary, variation applications for any changes to approved products or processes, and compliance with pricing regulations and drug pricing policies. Non-compliance can result in warning letters, fines, license suspension, or even cancellation, so maintaining robust compliance systems is essential.
🚀 Start Your Pharmaceutical Company Journey Today!
Complete end-to-end assistance for pharmaceutical company registration, licensing, and compliance
Or visit: Sterling.pk